National Heart, Lung, And Blood Institute (nhlbi)
Clinical trials sponsored by National Heart, Lung, And Blood Institute (nhlbi), explained in plain language.
-
New drug could help lung transplant patients fight off rejection
Disease control Not yet recruitingThis early-stage study tests a drug called fostamatinib in 30 adults who have had a lung transplant and developed donor-specific antibodies (DSA), which can lead to organ rejection. Participants take the drug or a placebo daily for 8 weeks while continuing standard care. The main…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Turmeric gel could ease sickle cell symptoms, early trial begins
Symptom relief Not yet recruitingThis early-stage study tests a skin gel made from turmeric (VAS-101) in 25 adults with stable sickle cell disease. The gel is applied to the forearms twice a week for 6 weeks to see if it is safe and well-tolerated. Researchers hope the gel helps the body absorb curcumin better t…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated May 17, 2026 03:23 UTC
-
Super-Computer boosts heart CT clarity in new study
Knowledge-focused Not yet recruitingThis study will take standard heart CT scans from 1,000 adults with structural heart disease and use a super-computer to create super high-resolution images. The goal is to see if these enhanced images show more detail than the originals. Participants get only their regular CT sc…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:26 UTC